The Taiho and UPMC-backed cancer biotherapeutics developer priced its shares in the middle of their range in its initial public offering.

Fosun is set to exit the mobile data-monitoring platform developer in an acqusition by Mobvista that will follow $36m of funding.

Eddyfi/NDT has agreed to purchase UCL spinout Senceive for an undisclosed amount.

Driverless vehicle developer EasyMile closed a $66.4m round featuring Alstom and Continental while UCB and LivaNova-backed EEG technology developer Ceribell secured $53m.

JD.com's logistics spinoff, which counts China Life and Tencent as investors, has received approval for an offering set to be between $3bn and $4bn in size.

Alibaba could potentially sell $550m of shares in the deal, which has been given approval by regulators and which will give Tata a 64% stake in return for $1.2bn.

The cybersecurity technology provider, which counts SB Isat among its early investors, has gone public in its home country.

GV, Tencent and Gilead Sciences will exit the vaccine and infectious disease drug developer in an initial public offering sized at about $110m.

Vaccitech, which developed the technology underlying Oxford’s covid vaccine, has priced its shares and will raise more than $110m in its IPO.

Huber+Suhner has acquired Cambridge spinout RoadMap Systems for an undisclosed amount.